Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 21,432 | 33,715 | 56,444 | 55,904 | 28,738 |
| Cost of Goods | 2,739 | 2,620 | 1,777 | 2,748 | 4,033 |
| Gross Profit | 18,693 | 31,095 | 54,667 | 53,156 | 24,705 |
| Operating Expenses | 124,523 | 124,365 | 122,747 | 84,910 | 31,708 |
| Operating Income | -105,091 | -92,650 | -67,302 | -31,007 | -6,970 |
| Interest Expense | 3,813 | 18,294 | 7,101 | 1,877 | 700 |
| Other Income | 20,571 | 7,261 | 7,148 | 10,261 | 10,128 |
| Pre-tax Income | -88,333 | -103,683 | -67,255 | -22,622 | 2,458 |
| Net Income Continuous | -88,333 | -103,683 | -67,255 | -22,622 | 2,458 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -3,750 |
| Minority Interests | -9,640 | -4,315 | N/A | 190 | -1,318 |
| Net Income | $-78,693 | $-99,368 | $-67,255 | $-22,812 | $27 |
| EPS Basic Total Ops | -1.93 | -2.78 | -1.91 | -0.67 | 0.00 |
| EPS Basic Continuous Ops | -2.17 | -2.91 | -1.91 | -0.66 | 0.09 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -0.14 |
| EPS Diluted Total Ops | -1.93 | -2.78 | -1.91 | -0.67 | 0.00 |
| EPS Diluted Continuous Ops | -2.17 | -2.91 | -1.91 | -0.66 | 0.09 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -0.14 |
| EPS Diluted Before Non-Recurring Items | -1.93 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-102,714 | $-89,279 | $-65,092 | $-29,068 | $-5,146 |